Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Nephroprotection in Perinatal Asphyxia
NCT07088328Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of pentoxifylline in perinatal asphyxia and hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Alexandria University. Primary endpoint: Renal function. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
pentoxifylline
03
Conditions
perinatal asphyxiahypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07088328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07088328.